Product Reports Resources Pricing Login Book a demo

eVariant

Biotech & Life Sciences · Farmington, United States · Founded 2008

Combines digital marketing, big data, and analytics into one platform for healthcare providers to improve patient engagement and physician alignment MoreLess

eVariant operated as a healthcare technology company focused on patient and physician engagement, founded in 2008 by Bill Moschella and Rob Grant. The firm established its niche by providing a cloud-based platform that integrated customer relationship management (CRM), marketing automation, and data analytics specifically for hospitals and healthcare systems. Its primary clients were hospital marketers and physician relations teams at mid-to-large-sized hospital networks across the United States. The company's business model was centered on its 'Patients for Life Platform,' a Software-as-a-Service (SaaS) solution designed to help healthcare providers acquire and retain high-value patients. This was achieved by enabling clients to launch targeted marketing campaigns and providing real-time data on physician referral streams, which allowed for precise analysis of marketing return on investment.

The platform's core function was to consolidate consumer, patient, provider, and claims data, and then apply proprietary analytics to yield actionable intelligence. This allowed healthcare systems to identify, guide, and maintain relationships with desired patient demographics and physicians. Key features included a healthcare-specific CRM, a physician relationship management (PRM) tool, and applications for call centers. A significant aspect of the platform was its ability to integrate with a hospital's existing clinical, billing, and other information systems. One of the platform's key selling points was its alignment with Salesforce, leveraging the latter's growing dominance in the enterprise healthcare market. Over its lifetime, eVariant raised approximately $98.8 million in funding from investors including Lightspeed Venture Partners, Goldman Sachs, and McKesson Ventures.

A major milestone in the company's history was its acquisition by Healthgrades in January 2020. The acquisition aimed to create a comprehensive, end-to-end engagement platform for a combined customer base of over 2,000 hospitals and life sciences clients. The merger combined eVariant's CRM and data analytics capabilities with Healthgrades' consumer-facing website and marketing services, offering a more scaled and integrated solution for health systems navigating industry consolidation. Following the transaction, eVariant shareholders retained a minority stake in the newly combined entity.

Keywords: healthcare CRM, patient engagement, physician relationship management, healthcare analytics, patient acquisition, patient retention, hospital marketing, Patients for Life Platform, Healthgrades, healthcare data analytics, provider network utilization, patient lifetime value, service line growth, healthcare SaaS, Bill Moschella, Rob Grant, healthcare consumer engagement, marketing automation, physician alignment, clinical data integration

Company overview

eVariant company information

The essential company record, classifications and operating signals in one place.

Status
Acquired
Founded
2008
Headquarters
Farmington, United States
Employees
24
Open positions
None listed
Dealroom signal
61.7
sub industryBioTechnologysub industryHealth Platformbusiness modelSaaSindustryHealthsectorAnalyticssectorData AnalyticssectorCRMsectorPredictive AnalyticssectorBiotechnologysectorPatient CaresectorHard TechsectorDT and LSsectorscience-basedindustryEnterprise Software

Valuation & funding

eVariant funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONOther financing Jan 2020 $0 Health Grades
SERIES COther financing Feb 2018 Goldman Sachs · Salesforce · McKesson Ventures
SERIES COther financing May 2016 Lightspeed Venture Partners · Salesforce · McKesson Ventures
SERIES COther financing Nov 2015 $42M $169M Goldman Sachs · Salesforce
SERIES BOther financing May 2014 $18M $73M Salesforce Ventures · Lightspeed Venture Partners
DEBTDebt Feb 2014 McKesson Ventures
EARLY VCOther financing Jun 2012 Undisclosed
SERIES AOther financing Nov 2011 Health Enterprise Partners
Showing 8 recorded eventsUnlock the complete deal history →

Growth signals

eVariant website traffic

Latest recorded traffic for eVariant is 410 monthly website visits, up 156.3% over the last three months. eVariant's team grew 0% over the past year.

Latest monthly visits410 3-month web change+156.3% 1-year team growth0%
Monthly website visits87 observations · Apr 2016–Nov 2024
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

eVariant compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

eVariant's talent

Book a demo to see the people
Team profiled 28 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

7 investors on eVariant's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 3 investors entered at this stage
Series B+ 3 investors entered at this stage
Other known 1 additional known investor
Health Grades

Global footprint

Where eVariant has talent and traffic

Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

In the news

Latest news about eVariant

Recent press, funding announcements, and product moves mentioning eVariant — open to read from the original sources.

See all news

Market sentiment

What the market is saying about eVariant

An AI-synthesized read of the highest-engagement posts about eVariant on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See eVariant’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.